Sort by
Refine Your Search
-
Applications are invited for an exceptional Postdoctoral Scientist to the join the group of Prof. Claus Nerlov to study blood cell development, with particular emphasis on mechanisms of HSC ageing
-
at the plasma membrane. The lab undertakes a multidisciplinary approach spanning biochemistry/biophysics, cell biology and structural biology to address our research questions. In this role you will build on our
-
and cell death. The Elliott group is embedded within the Department of Biochemistry and is at the forefront of the ubiquitin signalling field. The group employs a multifaceted approach including
-
Pay Scale: STANDARD RESEARCH GRADE 7 Salary (£): £41,997 - £46,913 per annum Location: Department of Biochemistry, South Parks Road, Oxford Contract type: Fixed Term contract for up to 3 years in the first instance Hours: Full Time (37.5 hours per week) PLEASE NOTE THAT THE CLOSING DATE FOR THIS...
-
Claudia Monaco’s research group at the Kennedy Institute of Rheumatology. In this role, you will apply single cell biology and cell signalling techniques combined with in vivo and in vitro models
-
. The post is funded by the EPSRC’s Centre to Centre (C2C) Grant, “Mobile Robotic Inspector: Learning to Explore and Manipulate in the Real World” and is fixed-term of 24 months duration. The project will
-
Research Associate to join an MRC-funded project investigating how immune checkpoint receptors regulate T-cell activation and function. Project Overview This project focuses on understanding the molecular
-
About the role We have an exciting opportunity to join the dynamic research group led by Dr Jie Yang in the Department of Oncology at the University of Oxford. The group conducts research on T cell
-
relevant PhD/DPhil in immunology or cell biology (or near completion) together with proven evidence for ability to independently lead and complete impactful research projects that address fundamental
-
data and presenting and writing papers or new grant proposals. You will specifically interrogate multiple Myeloma cell lines for studying the mechanism of action of epigenetic therapy in sensitive